Literature DB >> 6431468

Effects of carbamazepine and anti-depressant drugs on endogenous catecholamine levels in the cerebroventricular compartment of the rat.

S Kowalik, M Levitt, A I Barkai.   

Abstract

Concentrations of endogenous norepinephrine, dopamine and epinephrine in cerebroventricular perfusates were used to evaluate the effects of drugs on the availability of extracellular catecholamines in the intact rat brain. Administration of the antidepressant drugs imipramine, desmethylimipramine or tranylcypromine resulted in marked increases of both norepinephrine and dopamine concentrations while epinephrine levels were not affected. Treatment with a similar dose of carbamazepine - an anticonvulsant drug with antidepressant activity - resulted in a significant increase in dopamine concentrations without apparent effect on either norepinephrine or epinephrine. It is suggested that at the applied dose, carbamazepine may act to modify the uptake, release or metabolism of dopamine in brain areas adjacent to the cerebroventricular space without affecting the other catecholamines.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6431468     DOI: 10.1007/bf00429729

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  25 in total

1.  Trigeminal neuralgia: its treatment with a new anticonvulsant drug (G-32883).

Authors:  S BLOM
Journal:  Lancet       Date:  1962-04-21       Impact factor: 79.321

2.  High-performance liquid chromatographic radioenzymatic assay for plasma catecholamines.

Authors:  T S Klaniecki; C N Corder; R H McDonald; J A Feldman
Journal:  J Lab Clin Med       Date:  1977-10

3.  Therapeutic effects of carbamazepine in affective illness: a preliminary report.

Authors:  J C Ballenger; R M Post
Journal:  Commun Psychopharmacol       Date:  1978

4.  In vivo determination of endogenous biogenic amines in rat brain using HPLC and push-pull cannula.

Authors:  C C Loullis; J N Hingtgen; P A Shea; M H Aprison
Journal:  Pharmacol Biochem Behav       Date:  1980-06       Impact factor: 3.533

Review 5.  Psychopharmacological aspects of antiepileptic treatment.

Authors:  J Parnas; L Gram; H Flachs
Journal:  Prog Neurobiol       Date:  1980       Impact factor: 11.685

6.  Effect of carbamazepine on cyclic nucleotides in CSF of patients with affective illness.

Authors:  R M Post; J C Ballenger; T W Uhde; C Smith; D R Rubinow; W E Bunney
Journal:  Biol Psychiatry       Date:  1982-09       Impact factor: 13.382

7.  Demonstration of conjugated dopamine in monkey CSF by gas chromatography-mass spectrometry.

Authors:  M A Elchisak; K H Powers; M H Ebert
Journal:  J Neurochem       Date:  1982-09       Impact factor: 5.372

8.  Apparent turnover of norepinephrine in the intact rat brain estimated from its rate of appearance in the cerebroventricular compartment.

Authors:  M Levitt; S Kowalik; A I Barkai
Journal:  J Neurosci Res       Date:  1983       Impact factor: 4.164

9.  Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain.

Authors:  B K Koe
Journal:  J Pharmacol Exp Ther       Date:  1976-12       Impact factor: 4.030

10.  Potassium-induced release of [3H]catecholamine from brain: effects of pre-exposure to catecholamine uptake inhibitors.

Authors:  D Dembiec; G Cohen
Journal:  J Pharmacol Exp Ther       Date:  1981-06       Impact factor: 4.030

View more
  3 in total

Review 1.  Mechanisms of action of carbamazepine and its derivatives, oxcarbazepine, BIA 2-093, and BIA 2-024.

Authors:  António F Ambrósio; Patrício Soares-Da-Silva; Caetana M Carvalho; Arsélio P Carvalho
Journal:  Neurochem Res       Date:  2002-02       Impact factor: 3.996

2.  Double-blind comparison of carbamazepine and placebo for treatment of cocaine dependence.

Authors:  I D Montoya; F R Levin; P J Fudala; D A Gorelick
Journal:  Drug Alcohol Depend       Date:  1995-06       Impact factor: 4.492

3.  Assessment of the biomarkers of hepatotoxicity following carbamazepine, levetiracetam, and carbamazepine-levetiracetam adjunctive treatment in male Wistar rats.

Authors:  Opeyemi Samson Osuntokun; Ademola Adeniyi Babatunde; Gbola Olayiwola; Tope Gafar Atere; Olayemi Olutobi Oladokun; Kabiru Isola Adedokun
Journal:  Toxicol Rep       Date:  2021-03-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.